Insulet (NASDAQ:PODD) reported Q4 EPS of $0.24, $0.03 better than the analyst estimate of $0.21. Revenue for the quarter came in at $369.7 million versus the consensus estimate of $332.18 million.
Insulet (NASDAQ:PODD) reported Q4 EPS of $0.24, $0.03 better than the analyst estimate of $0.21. Revenue for the quarter came in at $369.7 million versus the consensus estimate of $332.18 million.